How should I adjust the insulin regimen for a 24‑week pregnant woman on insulin glargine (Lantus) 17 U nightly with acceptable fasting glucose but 1‑hour post‑prandial glucose of 188 and 158 mg/dL and a carbohydrate‑to‑insulin ratio of 1 U per 6 g?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Increase Prandial Insulin to Target Postprandial Excursions

Your patient's fasting glucose is acceptable at 122 mg/dL, but her 1-hour postprandial values of 188 and 158 mg/dL exceed the ADA target of 110–140 mg/dL; you should immediately increase her rapid-acting prandial insulin doses rather than adjust basal insulin. 1, 2

Why Prandial Insulin Needs Adjustment

  • The 1-hour postprandial target during pregnancy is 110–140 mg/dL, and your patient's values of 188 and 158 mg/dL are significantly above this threshold. 1, 2

  • Her fasting glucose of 122 mg/dL falls within the acceptable range of 70–95 mg/dL (though at the upper end), indicating that basal insulin glargine 17 units is providing adequate overnight coverage. 1, 2

  • Basal insulin alone does not control postprandial excursions; rapid-acting insulin (lispro or aspart) before each meal is required to address meal-related glucose spikes. 2

Specific Prandial Insulin Adjustment Algorithm

  • Increase her carbohydrate-to-insulin ratio from 1 unit per 6 grams to 1 unit per 5 grams (a 20% increase in prandial insulin) for the meals where postprandial glucose exceeds 140 mg/dL. 2

  • Titrate every 2–3 days by further tightening the ratio (e.g., 1:4.5, then 1:4) until 1-hour postprandial values consistently fall below 140 mg/dL. 2

  • At 24 weeks gestation, she is entering the phase of exponentially rising insulin resistance (weeks 17–36), during which insulin requirements typically increase by approximately 5% per week and may double or triple by week 36. 1, 2

Monitoring Requirements

  • Perform self-monitoring of blood glucose 4–6 times daily: fasting, before each meal (preprandial), and 1 hour after each meal. 1, 2

  • The 2-hour postprandial target is 100–120 mg/dL if you choose to monitor at 2 hours instead of 1 hour. 1, 2

  • Check A1C monthly with a target < 6% if achievable without significant hypoglycemia, or relax to < 7% if hypoglycemia becomes problematic. 1, 2

When to Adjust Basal Insulin

  • Only increase basal insulin glargine if fasting glucose rises above 95 mg/dL on consecutive days. 2

  • If fasting glucose exceeds 95 mg/dL, increase glargine by 2–4 units every 2–3 days until fasting values consistently fall below 95 mg/dL. 2

  • Given her current fasting glucose of 122 mg/dL, a modest basal increase of 2–3 units (to 19–20 units) may be warranted to bring fasting glucose closer to the lower end of the target range, but prandial insulin adjustment is the priority. 2

Critical Safety Considerations

  • Comprehensive hypoglycemia education for the patient and family is mandatory, as pregnancy attenuates counter-regulatory hormone responses and increases hypoglycemia risk, especially in the first trimester. 1, 2

  • A sudden unexplained drop in insulin requirements may signal placental insufficiency and requires immediate obstetric evaluation. 1, 2

  • Insulin glargine is acceptable during pregnancy despite limited randomized trial data, particularly for women already well-controlled on this regimen pre-pregnancy. 2, 3, 4

Multidisciplinary Referral

  • Referral to a specialized diabetes-and-pregnancy center with coordinated maternal-fetal medicine, endocrinology, diabetes education, and nutrition support is strongly recommended to manage the complex insulin adjustments required during pregnancy. 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Management in Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Management in Pregnancy Complicated by Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use of insulin glargine during pregnancy: A review.

Diabetes & metabolic syndrome, 2021

Guideline

Management of Diabetes in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How should I adjust the insulin glargine (Lantus) dose for my 35‑year‑old pregnant patient with fasting glucose 130 mg/dL (overnight 143 mg/dL) who is currently taking 60 units daily?
Can a patient with morning hypoglycemia take Lantus (insulin glargine) 14 units at night and 16 units during the day?
What adjustments should be made to a patient's regimen of 15 units of Lantus (insulin glargine) three times a day due to hyperglycemia?
What is the optimal time to administer basal insulin for an elderly female patient with hyperglycemia taking Lantus (insulin glargine) and Metformin (metformin hydrochloride)?
What should the Lantus (glargine) dose be for a patient with insulin-dependent diabetes, currently receiving 4 units/hour of insulin via drip and D5 (dextrose 5%) at 100ml/hr, once the D5 is stopped?
What is the appropriate ibuprofen dose for a 3‑year‑old child weighing 17 kg with fever using a 200 mg/5 mL suspension?
When should a healthy couple trying to conceive have intercourse relative to ovulation to maximize pregnancy chances?
What is the recommended initial levothyroxine dose for a healthy adult with primary hypothyroidism, and how should the starting dose be modified for patients ≥65 years, with coronary artery disease, heart failure, or frailty?
What dose of ibuprofen (200 mg/5 mL) should be given to a 4‑year‑old child weighing 14.6 kg with fever?
In a 28-year-old man with a chronic posterior anal fissure and skin tag refractory to conservative therapy, which surgical treatment is most appropriate?
What are the recommended indications, dosing regimen (loading and maintenance), renal dose adjustments, therapy duration, monitoring parameters, and alternative agents for teicoplanin in adult patients with serious Gram‑positive infections?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.